Cosmo Robotics develops and distributes wearable medical exoskeletons for lower-extremity gait rehabilitation, walking assistance for weakened and hemiplegic users, and industrial wearable suits.
The medical device portfolio is presented for rehabilitation settings and users with gait impairment associated with stroke, spinal cord injury, traumatic brain injury, Parkinson's disease, multiple sclerosis, cerebral palsy, and lower-limb weakness, while the industrial line is positioned for workers who frequently lift or handle heavy loads. Across the site, the company emphasizes natural walking pattern generation, walking-data collection and analysis, adjustable fit, and, on some systems, ankle actuation and smartphone or voice control; the company certification page lists FDA, CE, GMP, and ISO 13485, and the EA2 PRO page states KFDA certification, CE certification, and US FDA clearance as a medical device.
Related Articles: ExoAtlet’s Successful Journey To CE Marking (2021)
Founded in 2016 as ExoAtlet Asia, renamed Cosmo Robotics in 2024. The company originated from the ExoAtlet rehabilitation exoskeleton platform and continues that product lineage under the Cosmo Robotics brand, while related ExoAtlet-branded entities and legacy naming remain active in Europe and other markets.
